Press Releases

Human Birth Tissue Manufacturer is Scaling Up to Transition into a Biologics Provider

TissueTech Names New Vice President to Lead Human Resources Operations and Process Improvement Initiatives

Miami, FL – October 2, 2019 – TissueTech,TM Inc., a pioneer and market leader in the development and clinical application of human birth tissue products, today announced the appointment of Kim Tripodo to the role of Vice President of Human Resources. In this role, Ms. Tripodo will be responsible for all aspects of human resource […]


TissueTech Names New Vice President to Oversee Scale Up of Product Lifecycle Management and Technology Transfer Activities

Miami, FL – September 23, 2019 – TissueTechTM, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products, today announced the appointment of Jerry Chang, PhD to the position of Vice President of Product Development. In this new role, Dr. Chang will have oversight for ensuring the efficiency and integrity […]


TissueTech Appoints New Vice President to Drive Quality Assurance Strategy for all Product Development and Manufacturing Activities

Miami, FL – September 5, 2019 – TissueTechTM, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products, today announced the appointment of Sherry Saurini to the position of Vice President of Quality Assurance. In her new role, Ms. Saurini will have oversight for ensuring that the company is maintaining […]


TissueTech Expands its Clinical Program with Medidata’s End-to-end Unified Platform

Medidata Rave Clinical Cloud™ to help spearhead the company’s biologics transformation Unified platform creates a single source of truth for all data, enabling teams to focus on critical oversight activities, site satisfaction and improved patient experiences Miami, Fla. – July 3, 2019 – Medidata announced that TissueTech, Inc.. has chosen the Medidata Rave Clinical Cloud™ as its end-to-end platform […]


TissueTech Raises $82 million in latest round of equity financing

Miami, Fla. – June 26, 2019 – TissueTech, Inc., the pioneer in regenerative medicine utilizing human umbilical cord and amniotic membrane, today announced the closing of an $82.25 million round of Preferred C equity financing led by EW Healthcare Partners (formerly Essex Woodlands) and followed by the third round of continuous investments from Ballast Point […]


Amniox Medical Announces Positive Results from Phase 2 Pilot Trial of TTAX01 Cryopreserved Human Umbilical Cord for Complex Non-healing Diabetic Foot Ulcers

Miami, Fla. – May 9, 2019 – Amniox Medical, Inc., a TissueTech, Inc. company and leader in the clinical application of amniotic membrane and umbilical cord-based products, announced today the results from its successfully completed Phase 2 pilot trial of TTAX01 cryopreserved human umbilical cord for use in complex, non-healing diabetic foot ulcers (DFUs) at […]


Amniox Medical Announces Presentation of Phase 2 Diabetic Foot Ulcer Trial Results at Symposium on Advanced Wound Care Spring Meeting

Results highlight safety, effectiveness of cryopreserved human umbilical cord (TTAX01) in managing complex, non-healing DFUs complicated by osteomyelitis Miami, Fla. – May 7, 2019 – Amniox Medical, Inc., a TissueTech, Inc. company, announced today that the results of the Phase 2 pilot trial of its TTAX01 cryopreserved human umbilical cord for use in complex, non-healing […]


TissueTech, Inc. Awarded Patent for Compositions of Morselized Umbilical Cord and Amniotic Membrane

MIAMI – May 14, 2018 – TissueTech Inc., the pioneer in the development and clinical application of regenerative amniotic tissue-based products, announced that it has been awarded patent 9,808,491 by the U.S. Patent Trademark Office. The patent applies to the use of a gel composition comprising morselized placental amniotic membrane and/or morselized umbilical cord. as […]


TissueTech Appoints Dr. Frank Young Executive Vice President of Regulatory Affairs

MIAMI, FL – May 10, 2018 – TissueTech Inc., pioneers of the development and clinical application of amniotic tissue-based products, announced today the appointment of Dr. Frank Young as Executive Vice President of Regulatory Affairs. “Dr. Young’s appointment continues TissueTech’s tradition as a leader in innovation and quality,” said Amy Tseng, Chief Executive Officer of […]


Clinical Evidence Presented at SAWC on Application of Amniox Medical Products

MIAMI, FL – May 8, 2018 – Amniox Medical, Inc., a TissueTech, Inc. company, highlighted four clinical posters demonstrating the effectiveness of NEOX® Wound Allograft at the Symposium on Advanced Wound Care (SAWC) in April.